{"id":"angiotensin-ii-receptor-antagonists","safety":{"commonSideEffects":[{"rate":"5–10%","effect":"Dizziness"},{"rate":"2–5%","effect":"Hyperkalemia"},{"rate":"1–3%","effect":"Cough"},{"rate":"2–5%","effect":"Fatigue"},{"rate":"1–3%","effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These drugs selectively antagonize angiotensin II type 1 (AT1) receptors, preventing the hormone angiotensin II from exerting its vasoconstrictive and aldosterone-stimulating effects. By blocking AT1 receptor signaling, they reduce peripheral vascular resistance, lower blood pressure, and decrease sodium and water retention. This mechanism makes them effective for hypertension and heart failure management.","oneSentence":"Angiotensin II receptor antagonists block the binding of angiotensin II to AT1 receptors on blood vessels and other tissues, causing vasodilation and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:22.918Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure with reduced ejection fraction"},{"name":"Post-myocardial infarction"},{"name":"Diabetic nephropathy"}]},"trialDetails":[{"nctId":"NCT05168787","phase":"","title":"Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2020-08-13","conditions":"Heart Failure","enrollment":6558},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT04456816","phase":"PHASE2","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2020-08-31","conditions":"Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy","enrollment":23},{"nctId":"NCT07447206","phase":"PHASE2","title":"Vascular Intervention Strategies Trial for Alzheimer's","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-03","conditions":"Hypertension, Hypercholesterolemia, Dementia Risk Factors","enrollment":10},{"nctId":"NCT07167368","phase":"NA","title":"Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":"Cardiorenal Syndrome","enrollment":60},{"nctId":"NCT07292493","phase":"","title":"Immune System in Diabetic Kidney Disease","status":"ENROLLING_BY_INVITATION","sponsor":"University Medical Centre Ljubljana","startDate":"2025-12-01","conditions":"Diabetes, Diabetic Kidney Disease, Complement System","enrollment":90},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT07044700","phase":"","title":"Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2028-01-31","conditions":"Heart Failure of Reduced Ejection Fraction (HFrEF)","enrollment":5000},{"nctId":"NCT05183646","phase":"PHASE3","title":"A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB","status":"RECRUITING","sponsor":"Dimerix Bioscience Pty Ltd","startDate":"2022-05-30","conditions":"FSGS","enrollment":286},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT07355023","phase":"NA","title":"AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study","status":"RECRUITING","sponsor":"Tri-Service General Hospital","startDate":"2026-01-01","conditions":"Left Ventricular (LV) Systolic Dysfunction","enrollment":5000},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT05834803","phase":"NA","title":"Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-06-26","conditions":"Renovascular Hypertension, Renovascular Hypertension With Renal Failure, Heart Failure","enrollment":80},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT07295522","phase":"PHASE4","title":"Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Policlinico S. Donato","startDate":"2026-01-08","conditions":"Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)","enrollment":368},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT07261098","phase":"PHASE2","title":"The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chest Hospital","startDate":"2026-01-01","conditions":"Advanced Lung Cancer","enrollment":200},{"nctId":"NCT06183437","phase":"PHASE4","title":"The STOP-MED CTRCD Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-03-04","conditions":"Heart Failure, Cardiotoxicity, Cardiac Toxicity","enrollment":335},{"nctId":"NCT02966665","phase":"PHASE1","title":": Vascular Function in Health and Disease","status":"RECRUITING","sponsor":"Russell Richardson","startDate":"2008-09","conditions":"Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Heart Failure","enrollment":420},{"nctId":"NCT06700213","phase":"","title":"Guideline Directed Medical Therapy in Patients With Heart Failure","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2023-09-22","conditions":"Heart Failure","enrollment":300},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT05272878","phase":"PHASE3","title":"Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-22","conditions":"Acute Kidney Injury","enrollment":508},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT04884802","phase":"NA","title":"The GUARDIAN Trial","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-07-25","conditions":"Blood Pressure","enrollment":6254},{"nctId":"NCT06704633","phase":"PHASE4","title":"Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania","status":"NOT_YET_RECRUITING","sponsor":"Martin Rohacek","startDate":"2026-01-05","conditions":"Heart Failure","enrollment":238},{"nctId":"NCT03733145","phase":"PHASE4","title":"Angiotensin II in General Anesthesia","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-10-03","conditions":"Hypertension","enrollment":32},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT03476616","phase":"PHASE4","title":"Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients","status":"COMPLETED","sponsor":"Hippocration General Hospital","startDate":"2018-09-01","conditions":"Hypertension, Obesity","enrollment":198},{"nctId":"NCT05806138","phase":"PHASE2","title":"A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-07-17","conditions":"Breast Cancer, Cardiac Dysfunction","enrollment":21},{"nctId":"NCT04715568","phase":"PHASE4","title":"Secondhand Tobacco Smoke and Cardiovascular Disease","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-03-30","conditions":"Cardiovascular Diseases, Hypertension","enrollment":100},{"nctId":"NCT05237323","phase":"PHASE3","title":"Micophenolate Mofetil Versus Azathioprine in Myocarditis","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-10-01","conditions":"Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy","enrollment":50},{"nctId":"NCT01679132","phase":"NA","title":"BAROSTIM NEO Hypertension Pivotal Trial","status":"SUSPENDED","sponsor":"CVRx, Inc.","startDate":"2013-04-12","conditions":"Uncontrolled Hypertension","enrollment":10},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT04864145","phase":"NA","title":"Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2021-05-21","conditions":"Aortic Valve Disease","enrollment":210},{"nctId":"NCT07032116","phase":"","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","status":"NOT_YET_RECRUITING","sponsor":"Liu Hongfang","startDate":"2025-08-01","conditions":"Diabetic Kidney Disease (DKD)","enrollment":4472},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT04491136","phase":"PHASE4","title":"Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-11-11","conditions":"Heart Failure","enrollment":201},{"nctId":"NCT06838416","phase":"","title":"Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2023-11-17","conditions":"Type 2 Diabetes Mellitus, Chronic Kidney Disease, Renal Function","enrollment":300},{"nctId":"NCT00429364","phase":"PHASE3","title":"Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome","status":"COMPLETED","sponsor":"Carelon Research","startDate":"2007-01","conditions":"Marfan Syndrome","enrollment":608},{"nctId":"NCT02378805","phase":"","title":"Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome","status":"RECRUITING","sponsor":"University Hospital Goettingen","startDate":"1995-07","conditions":"Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease","enrollment":800},{"nctId":"NCT03122834","phase":"","title":"Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart Failure","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-04-15","conditions":"Heart Failure","enrollment":246},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT05759754","phase":"NA","title":"Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2023-09-17","conditions":"Proteinuria, Kidney Diseases, Hereditary Nephropathy","enrollment":72},{"nctId":"NCT06654596","phase":"NA","title":"Efficacy and Safety of Telitacicept in IgAN","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-12-06","conditions":"IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept","enrollment":118},{"nctId":"NCT06157580","phase":"EARLY_PHASE1","title":"Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia","status":"COMPLETED","sponsor":"Anna Stanhewicz, PhD","startDate":"2023-12-08","conditions":"Preeclampsia","enrollment":24},{"nctId":"NCT04768322","phase":"NA","title":"LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-02-24","conditions":"End-stage Heart Failure","enrollment":92},{"nctId":"NCT04913870","phase":"PHASE4","title":"Angiotensin Receptor Blockers in Aortic Stenosis","status":"RECRUITING","sponsor":"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","startDate":"2020-02-01","conditions":"Aortic Stenosis, Aortic Valve Stenosis","enrollment":144},{"nctId":"NCT06711432","phase":"NA","title":"Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-09-18","conditions":"Tumor, Stroke","enrollment":214},{"nctId":"NCT04647396","phase":"NA","title":"Biomarker-guided Intervention to Prevent Acute Kidney Injury","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2020-11-17","conditions":"Acute Kidney Injury","enrollment":1180},{"nctId":"NCT05709444","phase":"PHASE2","title":"A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease","status":"COMPLETED","sponsor":"Palatin Technologies, Inc","startDate":"2022-12-26","conditions":"Kidney Disease","enrollment":16},{"nctId":"NCT06635616","phase":"","title":"Hypertension Management in Terms of Routine Agents","status":"NOT_YET_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-11-01","conditions":"Hypertension, Emergency Medicine","enrollment":350},{"nctId":"NCT05637216","phase":"PHASE2","title":"Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients","status":"RECRUITING","sponsor":"Shaw Cancer Center","startDate":"2023-08-17","conditions":"Radiation Induced Fibrosis","enrollment":40},{"nctId":"NCT05164653","phase":"PHASE4","title":"Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saga University","startDate":"2021-12-27","conditions":"Heart Failure","enrollment":400},{"nctId":"NCT05169411","phase":"","title":"Preserving Kidney Function in Children With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-09-22","conditions":"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease","enrollment":20240},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT06501651","phase":"PHASE4","title":"Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Academy of Medical Sciences","startDate":"2024-08-01","conditions":"Essential Hypertension, Type 2 Diabetes, Nephropathy","enrollment":297},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT05364190","phase":"PHASE3","title":"Canagliflozin in Patients With Acute Decompansted Heart Failure","status":"COMPLETED","sponsor":"October 6 University","startDate":"2022-06-04","conditions":"Chronic Heart Failure, Acute Heart Failure, Diabetes Mellitus","enrollment":142},{"nctId":"NCT05269615","phase":"PHASE4","title":"Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2023-03-20","conditions":"Exercise Physiology","enrollment":80},{"nctId":"NCT06382571","phase":"","title":"Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2016-01-01","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":396},{"nctId":"NCT05818995","phase":"","title":"Therapeutic Drug Use for CKD Patients","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2022-07-01","conditions":"Chronic Kidney Disease","enrollment":10000},{"nctId":"NCT02597361","phase":"PHASE3","title":"Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-01","conditions":"Ehlers-Danlos Syndrome, Vascular Type","enrollment":61},{"nctId":"NCT06278727","phase":"","title":"Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-01-01","conditions":"Mitral Regurgitation, Heart Failure","enrollment":270},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT00456963","phase":"PHASE4","title":"Prevention of Diabetes and Hypertension","status":"TERMINATED","sponsor":"Istituto Auxologico Italiano","startDate":"2007-09","conditions":"Diabetes Mellitus, Hypertension","enrollment":3000},{"nctId":"NCT06201000","phase":"","title":"Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-12-27","conditions":"Genetic Polymorphisms, Heart Failure","enrollment":282},{"nctId":"NCT02351063","phase":"NA","title":"HF Assessment With BNP in the Home: Part II","status":"TERMINATED","sponsor":"Alere San Diego","startDate":"2014-04","conditions":"Heart Failure","enrollment":1},{"nctId":"NCT03164785","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease","status":"COMPLETED","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2017-07-24","conditions":"Type 2 Diabetes Mellitus, Diabetic Kidney Disease","enrollment":202},{"nctId":"NCT06175663","phase":"","title":"Hyperintense: Midlife Hypertension and the Brain","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2021-07-06","conditions":"Hypertension, Small Vessel Cerebrovascular Disease","enrollment":130},{"nctId":"NCT05157464","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2023-09-01","conditions":"Arthrofibrosis","enrollment":""},{"nctId":"NCT04506372","phase":"NA","title":"Management of Angiotensin Inhibitors During the Perioperative Period","status":"TERMINATED","sponsor":"UMC Utrecht","startDate":"2020-09-11","conditions":"Surgery, Angiotensin Hypertension, Perioperative Complication","enrollment":342},{"nctId":"NCT03686696","phase":"PHASE4","title":"Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT","status":"TERMINATED","sponsor":"Uppsala University","startDate":"2018-12-16","conditions":"Myocardial Infarction With Non-obstructive Coronary Arteries","enrollment":198},{"nctId":"NCT03957161","phase":"NA","title":"ACEi ARB Withdrawal in CKD Patients","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2023-11","conditions":"Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor","enrollment":""},{"nctId":"NCT03951142","phase":"PHASE2","title":"Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study","status":"UNKNOWN","sponsor":"Kyrre Eeg Emblem","startDate":"2019-10-01","conditions":"Glioblastoma, Brain Metastases","enrollment":165},{"nctId":"NCT05212649","phase":"","title":"Optimized Peak VO2 in Predicting Advanced HF","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2014-05-01","conditions":"Heart Failure, Morality, Transplant; Failure, Heart","enrollment":377},{"nctId":"NCT02364089","phase":"NA","title":"Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2015-04-09","conditions":"Adrenal Incidentalomas","enrollment":78},{"nctId":"NCT05948969","phase":"NA","title":"Transform CV Risk in Diabetes","status":"UNKNOWN","sponsor":"American College of Cardiology","startDate":"2023-09-01","conditions":"Type 2 Diabetes","enrollment":750},{"nctId":"NCT05418361","phase":"","title":"The Effect of RAAS Blockers on ACE2 Levels","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-06-15","conditions":"Renin-Angiotensin System","enrollment":100},{"nctId":"NCT03552575","phase":"PHASE3","title":"The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2018-07-01","conditions":"Heart Failure","enrollment":93},{"nctId":"NCT05824390","phase":"PHASE4","title":"A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy","status":"UNKNOWN","sponsor":"XIEJINGYUAN","startDate":"2020-06-20","conditions":"IgA Nephropathy","enrollment":116},{"nctId":"NCT00309257","phase":"PHASE2","title":"Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2004-01","conditions":"Alport Syndrome","enrollment":9},{"nctId":"NCT04364984","phase":"","title":"ARB, ACEi, DRi Effects on COVID-19 Course Disease","status":"COMPLETED","sponsor":"Medical Practice Prof D. Ivanov","startDate":"2020-04-01","conditions":"Hypertension, COVID-19","enrollment":112},{"nctId":"NCT03315832","phase":"PHASE2, PHASE3","title":"Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study","status":"WITHDRAWN","sponsor":"University Hospital, Limoges","startDate":"2023-01-02","conditions":"Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists","enrollment":""},{"nctId":"NCT03082014","phase":"PHASE3","title":"Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function","status":"TERMINATED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2018-02-22","conditions":"Cerebral Small Vessel Diseases","enrollment":101},{"nctId":"NCT02188121","phase":"PHASE4","title":"Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2015-02","conditions":"Serious Mental Illness, Schizophrenia, Schizoaffective Disorder","enrollment":227},{"nctId":"NCT04351581","phase":"NA","title":"Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2020-05-18","conditions":"Covid-19","enrollment":78},{"nctId":"NCT05633758","phase":"PHASE2","title":"Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Scripps Health","startDate":"2014-03","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT04129840","phase":"NA","title":"Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-03-05","conditions":"Arterial Hypertension","enrollment":1268},{"nctId":"NCT04353596","phase":"PHASE4","title":"Stopping ACE-inhibitors in COVID-19","status":"COMPLETED","sponsor":"Medical University Innsbruck","startDate":"2020-04-20","conditions":"SARS-CoV-2, COVID-19","enrollment":216},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT05398731","phase":"","title":"Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-06","conditions":"COVID-19 Pneumonia","enrollment":400},{"nctId":"NCT00541268","phase":"NA","title":"Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality","status":"COMPLETED","sponsor":"Danish Study Group","startDate":"2008-02","conditions":"Heart Failure, Dilated Cardiomyopathy, Reduced LVEF","enrollment":1116},{"nctId":"NCT03529838","phase":"NA","title":"Hemodynamic and Salivary Responses of 12 Weeks of Training With Different Anti-hypertensive","status":"TERMINATED","sponsor":"Federal University of Uberlandia","startDate":"2017-03-01","conditions":"Hypertension, Menopause","enrollment":30},{"nctId":"NCT04394117","phase":"PHASE4","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","status":"COMPLETED","sponsor":"The George Institute","startDate":"2020-06-19","conditions":"Coronavirus Disease 2019, COVID-19","enrollment":787},{"nctId":"NCT00159588","phase":"NA","title":"Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2004-01","conditions":"Headache","enrollment":64},{"nctId":"NCT02721342","phase":"","title":"Remission Clinic in Proteinuric Chronic Nephropathies","status":"UNKNOWN","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2009-06","conditions":"Chronic Kidney Disease","enrollment":1500},{"nctId":"NCT05240443","phase":"NA","title":"Bariatric Surgery and Chronic Renal Disease","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2022-04-01","conditions":"Bariatric Surgery, Chronic Kidney Diseases, Obesity","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1034,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Angiotensin II Receptor Antagonists","genericName":"Angiotensin II Receptor Antagonists","companyName":"Nara Medical University","companyId":"nara-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Angiotensin II receptor antagonists block the binding of angiotensin II to AT1 receptors on blood vessels and other tissues, causing vasodilation and reducing blood pressure. Used for Hypertension, Heart failure with reduced ejection fraction, Post-myocardial infarction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}